Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LG-TAP block for pain after gastric bypass
NCT06614257Completed
- Sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico
- Start
- Jan 2022
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Fondazione Policlinico Universitario Campus Bio-Medico. Primary endpoint: Pain Score at 24 hours. Started Jan 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06614257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06614257.